Valeant Pharmaceuticals reported $1.49B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Amgen AMGN:US $ 4889M 478M
Ani Pharmaceuticals ANIP:US $ 26.31M 8.22M
Aphria Inc APH:CN C$ -7278000 20.68M
Aurora Cannabis Inc ACB:CN -61070000 40.9M
Biogen BIIB:US $ 2267.1M 48.2M
Bristol Myers Squibb BMY:US $ 9252M 682M
Canopy Growth Corp WEED:CN C$ 27.24M 17.44M
Catalent CTLT:US $ 439.3M 73.7M
Corcept Therapeutics CORT:US $ 90.2M 12.04M
Danaher DHR:US $ 4359M 38M
Drreddys Laboratories RDY:US $ 25699M 324M
Eli Lilly And LLY:US $ 5342M 555.1M
Endo International Ordinary Shares ENDP:US $ 400.4M 27.52M
Gilead Sciences GILD:US $ 4827M 235M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Horizon Pharma HZNP:US $ 631.55M 389.52M
JAZZ PHA JAZZ:US $ 632.62M 65.22M
Lannett LCI:US $ 22.66M 3.8M
Nektar Therapeutics NKTR:US $ 20.66M 2.77M
Pacira Pharmaceuticals PCRX:US $ 100.34M 12.66M
Perrigo Ordinary Shares PRGO:US $ 349M 19.4M
Phibro Animal Health PAHC:US $ 69.83M 0.66M
Prestige Brands PBH:US $ 159.01M 21.96M
Revance Therapeutics RVNC:US $ 13.38M 4.3M
Supernus Pharmaceuticals SUPN:US $ 116.3M 0.32M
Valeant Pharmaceuticals VRX:CN $ 1488M 35M
Vertex Pharmaceuticals VRTX:US $ 1565.4M 33.42M
Zoetis ZTS:US $ 1384M 56M